Amazon.com, Inc. (AMZN)’s Low Priced Mobile Credit Card Reader All Set To Oust Square And PayPal

Amazon.com, Inc. (NASDAQ:AMZN) has unveiled ‘Local Register.’ It currently comes with a free app and merchants are charged a one-time fee of $10. Those who sign up before the end of October get a special rate of 1.75 % per swipe. This rate will be valid till January 1, 2016 after which it will go up by 0.75 percentage points to 2.5 % per swipe. CNBC’s ‘Squawk on the Street’ team talks about this new venture of Amazon and how it will affect current market leaders Square and PayPal.

is amazon a good stock to buy, amazn vs content, Amazon.com, Inc. (NASDAQ:AMZN), amazon stops pre-orders for disney movies

“[Amazon] charging 1.75 is a full point below Square. That’s going to get some small business owners’ attention”, said journalist and Squawk on the Street co-host Carl Quintanilla referring to Amazon.com, Inc. (NASDAQ:AMZN)’s offer to charge merchants 1.75 % per swipe for purchases using Local Register whereas Square currently charges 2.75 % per swipe. The one-time fee of $10 will also be repaid as transaction credit.

Amazon.com, Inc. (NASDAQ:AMZN) is famous for luring customers by cutting charges policy. It had followed the same previously for Amazon Web Services, its extremely successful cloud offering for small businesses.

“They try a lot of different things out and they do typically come in and not just undercut but then continue to push prices down à la AWS, Amazon Web Services [...]”, added market news analyst and Squawk on the Street co-host David Faber.

Now that most of the world is shifting to credit cards with embedded microchips, Square recently announced the launch of its chip-compatible dongle to keep up with the changing times. This gives Square one point over Amazon.com, Inc. (NASDAQ:AMZN) albeit for a limited time until the latter alters its current device suitably. The overall verdict is that Amazon’s Local Register will definitely give tough competition to existing services offered by Square and PayPal.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!